⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
QTRX News
Quanterix Corporation Common Stock
Quetzal Therapeutics Announces First Patient Dosed in Phase 3 QUATRO-APL Trial of QTX-2101 for Frontline Acute Promyelocytic Leukemia
globenewswire.com
QTRX
Form 8-K
sec.gov
QTRX
Form 8-K
sec.gov
QTRX
Form 8-K
sec.gov
QTRX
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
QTRX
Form 8-K
sec.gov
QTRX
Quanterix Announces Planned Transition of Chief Financial Officer
businesswire.com
QTRX
Form 8-K
sec.gov
QTRX
Quanterix Releases Financial Results for the First Quarter of 2026
businesswire.com
QTRX
Quanterix To Report First Quarter 2026 Financial Results on May 6, 2026
businesswire.com
QTRX